Categories: News

WHO coordinates expansion of Ebola treatment centre in DR Congo as death toll climbs

By Rédaction Africanews and AP

The Ebola outbreak in the Democratic Republic of the Congo has claimed more than 3,000 lives, according to latest figures from the World Health Organization (WHO). To support the fight against Ebola, WHO is coordinating and funding the expansion of the Lita treatment centre in Ituri province. The extension will add 42 beds, improve health and hygiene facilities, and increase treatment capacity.

The deadliest ever Ebola outbreak in the Democratic Republic of Congo has now claimed the lives of more than 3,000 people, according to the latest official toll released on Wednesday. The epidemic, which has hit the conflict-hit east and northeast of the country, has caused 3,007 deaths and infected 6,186 people, the Congolese National Institute of Public Health said.

The fatality rate is 48.6 percent. A total of 1,409 people have been reported to have recovered, it added. Ebola, which is transmitted through contact with bodily fluids and causes haemorrhagic fever, has killed more than 15,000 people in Africa in the last 50 years.

The worst outbreak previously recorded in DR Congo left nearly 2,300 people dead from 3,500 reported cases between 2018 and 2020. The current outbreak originated in the remote northeastern province of Ituri and is caused by the Bundibugyo strain, for which there is currently no approved vaccine or treatment.

The virus has spread to six provinces and is ravaging areas where the presence of the Congolese state is weak and insecurity is widespread due to the presence of armed groups.

The health response lacks sufficient resources and has been overwhelmed by the surge in cases, while there has been widespread mistrust in parts of the community. Several treatments and vaccines are being tested against the Bundibugyo strain.

Approved vaccines are only effective against the Zaire strain, which is responsible for the largest-known Ebola outbreak to date. The World Health Organization has in the meantime recommended the implementation of a phase three clinical trial using the Ervebo vaccine deployed against the Zaire strain.

WHO experts are still unclear as to whether Ervebo protects humans against Bundigbugyo but initial data suggests that it could offer a degree of protection. A batch of 16,250 doses for use by frontline medical personnel arrived in DR Congo at the end of last month and vaccination began shortly afterwards in Kisangani, the capital of Tshopo province in the northeast.

Advertisements
Montage Africa

Recent Posts

Botswana, Ivory Coast sign mining, energy, trade deals

By Rédaction Africanews and AFP Botswana’s President Duma Boko arrived in Abidjan on Monday at…

4 hours ago

2027 Grammy nominations: African artists take four of five global album spots

By Rédaction Africanews African artists account for four of the five nominees for Best Global…

4 hours ago

Three women join the race to become Haiti’s next president

By AP For the first time in Haiti’s history, three women have registered as presidential…

4 hours ago

HRW: Rwanda ‘migration hub’ plan risks violating international law

By Rédaction Africanews and AP Five European countries planning to send rejected asylum seekers to…

4 hours ago

Guinea jails more than 220 people in deadly crackdown on illegal gold mining

By Rédaction Africanews and AP Guinea is stepping up its fight against illegal gold mining,…

4 hours ago

Ethiopia-Moyale clashes disrupt livelihoods as territorial dispute deepens

By Al Jazeera Moyale, Ethiopia – Fighting involving police and armed groups affiliated with Ethiopia’s Oromia…

4 hours ago